GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » COGS-to-Revenue

MicroPort CardioFlow Medtech (HKSE:02160) COGS-to-Revenue : 0.29 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech COGS-to-Revenue?

MicroPort CardioFlow Medtech's Cost of Goods Sold for the six months ended in Jun. 2024 was HK$69.9 Mil. Its Revenue for the six months ended in Jun. 2024 was HK$240.2 Mil.

MicroPort CardioFlow Medtech's COGS to Revenue for the six months ended in Jun. 2024 was 0.29.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. MicroPort CardioFlow Medtech's Gross Margin % for the six months ended in Jun. 2024 was 70.91%.

MicroPort CardioFlow Medtech COGS-to-Revenue Historical Data

The historical data trend for MicroPort CardioFlow Medtech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech COGS-to-Revenue Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.71 0.56 0.41 0.35 0.32

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.36 0.35 0.34 0.29 0.29

MicroPort CardioFlow Medtech COGS-to-Revenue Calculation

MicroPort CardioFlow Medtech's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=116.251 / 367.745
=0.32

MicroPort CardioFlow Medtech's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=69.883 / 240.218
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort CardioFlow Medtech  (HKSE:02160) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

MicroPort CardioFlow Medtech's Gross Margin % for the six months ended in Jun. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 69.883 / 240.218
=70.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

MicroPort CardioFlow Medtech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort CardioFlow Medtech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » COGS-to-Revenue
Comparable Companies
HKSE:06669 HKSE:02235 HKSE:09877 HKSE:01696 HKSE:09996 HKSE:02407 HKSE:06922 HKSE:06609 HKSE:02170 HKSE:01763 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
72X:Germany
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
Website
https://www.cardioflowmedtech.com
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.
Executives
Microport Scientific Corporation 2201 Interest of corporation controlled by you
China Renaissance Holdings Limited 2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si 2201 Interest of corporation controlled by you
Shanghai Microport Limited 2101 Beneficial owner
China International Capital Corporation Limited 2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd. 2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership) 2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd. 2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech Headlines

No Headlines